Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bright Minds Biosciences (DRUG) Cash from Operations: 2019-2021

Historic Cash from Operations for Bright Minds Biosciences (DRUG) over the last 1 years, with Sep 2021 value amounting to -$9.7 million.

  • Bright Minds Biosciences' Cash from Operations fell 3441.42% to -$9.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$5.8 million, marking a year-over-year change of. This contributed to the annual value of -$1.4 million for FY2024, which is 73.89% up from last year.
  • As of Q3 2021, Bright Minds Biosciences' Cash from Operations stood at -$9.7 million, which was down 502.36% from $2.4 million recorded in Q2 2021.
  • In the past 5 years, Bright Minds Biosciences' Cash from Operations ranged from a high of $2.4 million in Q2 2021 and a low of -$9.7 million during Q3 2021.
  • Over the past 3 years, Bright Minds Biosciences' median Cash from Operations value was $194,842 (recorded in 2019), while the average stood at -$1.0 million.
  • Data for Bright Minds Biosciences' Cash from Operations shows a maximum YoY slumped of 3,441.42% (in 2021) over the last 5 years.
  • Over the past 3 years, Bright Minds Biosciences' Cash from Operations (Quarterly) stood at -$31,827 in 2019, then crashed by 763.32% to $421,510 in 2020, then tumbled by 3,441.42% to -$9.7 million in 2021.
  • Its last three reported values are -$9.7 million in Q3 2021, $2.4 million for Q2 2021, and $1.1 million during Q1 2021.